Morgan Stanley’s Counterpoint Global eyes potential of psychedelics
Morgan Stanley's Counterpoint Global team, a collective of investors and researchers, has turned its focus to the potential of psychedelics.…
Morgan Stanley report highlights potential of psychedelic drugs in mental health treatment
Morgan Stanley, one of the world's leading investment banks, has published a report on the potential of psychedelic drugs in…
